Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001558370-19-011699
Filing Date
2019-12-30
Accepted
2019-12-30 11:22:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 425 42394
2 EX-99.1 ex-99d1.htm EX-99.1 10616
  Complete submission text file 0001558370-19-011699.txt   54489
Mailing Address P.O. BOX 130235 ANN ARBOR MI 48113
Business Address P.O. BOX 130235 ANN ARBOR MI 48113 734-245-1700
Gemphire Therapeutics Inc. (Filed by) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 130235 ANN ARBOR MI 48113
Business Address P.O. BOX 130235 ANN ARBOR MI 48113 734-245-1700
Gemphire Therapeutics Inc. (Subject) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-37809 | Film No.: 191315468
SIC: 2834 Pharmaceutical Preparations